Lista de obras - Jesus Yamamoto-Furusho - Dominio Público Uruguay

Antinuclear antibodies: A marker associated with steroid dependence in patients with ulcerative colitis

artículo científico publicado en 2009

Association of GIST and Somatostatinoma in a Patient With Type-1 Neurofibromatosis: Is There a Common Pathway?

artículo científico publicado en 2009

Association of HLA-DR3 and HLA-DR4 with Sinonasal Polyposis in Mexican Mestizos

scientific article published on 01 July 2006

Association of HLA-DR4 (DRB1*0404) With Human Papillomavirus Infection in Patients With Focal Epithelial Hyperplasia

article

Association of HLA-DRB1*16 with chronic discoid lupus erythematosus in Mexican mestizo patients.

artículo científico publicado en 2007

Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis

artículo científico publicado en 2006

Association of the interleukin 15 (IL-15) gene polymorphisms with the risk of developing ulcerative colitis in Mexican individuals

article

Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

artículo científico publicado en 2007

Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease.

artículo científico publicado en 2018

Centaurin beta1 down-regulates nucleotide-binding oligomerization domains 1- and 2-dependent NF-kappaB activation

artículo científico publicado en 2006

Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis.

artículo científico publicado en 2003

Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006).

artículo científico publicado en 2009

Colonic epithelial upregulation of interleukin 22 (IL-22) in patients with ulcerative colitis

scientific article published on 01 November 2010

Complotype SC30 Is Associated With Susceptibility to Develop Ulcerative Colitis in Mexicans

article

Crohn's disease: innate immunodeficiency?

artículo científico publicado en 2006

Cytomegalovirus Infection in Patients Who Required Colectomy for Toxic Megacolon or Severe Steroid-Refractory Ulcerative Colitis

article

Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.

artículo científico publicado en 2016

Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis

artículo científico publicado en 2020

Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease

artículo científico publicado en 2018

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.

artículo científico publicado en 2015

Differential expression of occludin in patients with ulcerative colitis and healthy controls

artículo científico publicado en 2011

Distinguishing Between Anti-Neutrophil Cytoplasmic Antibody Patterns in Inflammatory Bowel Disease: Is the “Atypical Pattern” Adding More Information?

scientific article published on 12 May 2009

Effect of Cis-palmitoleic acid supplementation on inflammation and expression of HNF4γ, HNF4α and IL6 in patients with ulcerative colitis.

artículo científico publicado en 2017

Evaluation of a vaccination regimen and care in relation to follow-up and treatment of patients with inflammatory bowel disease

artículo científico publicado en 2018

Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire

artículo científico publicado en 2015

Expression of HNF4γ is downregulated in patients with active ulcerative colitis (UC) compared to UC patients in remission and healthy controls.

artículo científico publicado en 2011

Expression of TOB/BTG Family members in Patients with Inflammatory Bowel Disease

artículo científico publicado en 2020

Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study

artículo científico publicado en 2014

Frequency, Clinical Features and Factors Associated with Pouchitis after Proctocolectomy with Ileo-Pouch-Anal Anastomosis in Patients with Ulcerative Colitis: A Latin-American Country Retrospective-Cohort Study

artículo científico publicado en 2015

Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo

article

Gene Expression Profiling of Mediators Associated with the Inflammatory Pathways in the Intestinal Tissue from Patients with Ulcerative Colitis

artículo científico publicado en 2020

Gene and protein expression of centaurin beta 1 (CENTB1) are up-regulated in patients with ulcerative colitis ⬇️

artículo científico publicado el 11 de enero de 2013

Gene expression of carnitine organic cation transporters 1 and 2 (OCTN) is downregulated in patients with ulcerative colitis.

artículo científico publicado en 2010

Gene expression of solute carrier family 9 (sodium/hydrogen exchanger) 3, (SLC9A3) is downregulated in patients with ulcerative colitis.

artículo científico publicado en 2012

Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.

artículo científico

Genetic factors associated with the development of inflammatory bowel disease.

artículo científico publicado en 2007

Genetic polymorphisms of interleukin 20 (IL-20) in patients with ulcerative colitis.

artículo científico publicado en 2012

Genetic polymorphisms of interleukin-22 in patients with ulcerative colitis.

artículo científico publicado en 2016

HLA Study on Two Mexican Mestizo Families with Autoimmune Thyroid Disease

artículo científico publicado en 2002

HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis.

artículo científico publicado en 2003

HLA-DR6 (possibly DRB1*1301) is associated with susceptibility to Takayasu arteritis in Mexicans

article

HLA-DR7 in Association with Chlorpromazine-induced Lupus Anticoagulant (LA)

artículo científico publicado en 1997

HLA-DRB1 alleles are associated with the clinical course of disease and steroid dependence in Mexican patients with ulcerative colitis.

artículo científico publicado en 2010

HLA-DRB1*08 allele may help to distinguish between type 1 diabetes mellitus and type 2 diabetes mellitus in Mexican children.

artículo científico publicado en 2007

HLA-DRB1∗04 is associated with the genetic susceptibility to develop vitiligo in Mexican patients with autoimmune thyroid disease

artículo científico publicado en 2005

Haplotype Distribution of Class II MHC Genes in Mexican Patients with Systemic Lupus Erythematosus

article

High gene expression of CXCL8 is associated with the presence of extraintestinal manifestations and long-term disease in patients with ulcerative colitis.

artículo científico publicado en 2013

High gene expression of MDR1 (ABCB1) is associated with medical treatment response and long-term remission in patients with ulcerative colitis.

artículo científico publicado en 2010

Histopathologic Parameters at Diagnosis as Early Predictors of Histologic Remission along the Course of Ulcerative Colitis

artículo científico publicado en 2020

IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis.

artículo científico publicado en 2012

Immunologic, genetic and social human risk factors associated to histoplasmosis: studies in the State of Guerrero, Mexico ⬇️

artículo científico publicado el 1 de enero de 1997

Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.

artículo científico

Increased expression of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) and MMP10, MMP23 in inflammatory bowel disease: cross-sectional study

scientific article published on 27 August 2020

Increased expression of discs large homolog 5 gene (DLG5) in ulcerative colitis patients compared to healthy individuals.

artículo científico publicado en 2010

Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study.

artículo científico publicado en 2013

Infection frequency in patients with chronic idiopathic ulcerative colitis

artículo científico publicado en 2012

Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.

artículo científico publicado en 2008

Innate immunity in inflammatory bowel disease.

artículo científico publicado en 2007

Innovative therapeutics for inflammatory bowel disease

artículo científico publicado en 2007

Interleukin 1 β (IL-1B) and IL-1 Antagonist Receptor (IL-1RN) Gene Polymorphisms are Associated With the Genetic Susceptibility and Steroid Dependence in Patients With Ulcerative Colitis

article

Interleukin 17 gene and protein expression are increased in patients with ulcerative colitis

artículo científico publicado el 14 de julio de 2011

Interleukin 21 expression is increased in rectal biopsies from patients with ulcerative colitis.

artículo científico publicado en 2010

Interleukin 27 is up-regulated in patients with active inflammatory bowel disease

artículo científico publicado en 2016

Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease

artículo científico publicado en 2015

Interleukin-18 upregulation is associated with the use of steroids in patients with ulcerative colitis

artículo científico publicado en 2011

Intestinal protozoa infections among patients with ulcerative colitis: prevalence and impact on clinical disease course.

artículo científico publicado en 2010

Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study

artículo científico publicado en 2017

Leiden V Factor and Spastic Cerebral Palsy in Mexican Children

artículo científico publicado en 2012

Marcadores serológicos en enfermedad inflamatoria intestinal: diferencias poblacionales y limitaciones de su aplicación

artículo científico publicado en 2009

Mild clinical behaviour of Crohn disease in elderly patients in a Latin American country: A case-control study

artículo científico publicado en 2015

Mortality and Hospitalizations in Mexican Patients with Inflammatory Bowel Disease: Results from a Nationwide Health Registry

artículo científico publicado en 2020

Perinuclear anti-neutrophil cytoplasmic antibodies (p-anca) in chronic ulcerative colitis: experience in a Mexican institution.

artículo científico publicado en 2006

Peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression is downregulated in patients with active ulcerative colitis.

artículo científico publicado en 2011

Peroxisome proliferator-activated receptors family is involved in the response to treatment and mild clinical course in patients with ulcerative colitis

artículo científico publicado en 2014

Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies

artículo científico publicado en 2017

Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.

artículo científico publicado en 2004

Protective role of Interleukin 27 (IL-27) gene polymorphisms in patients with ulcerative colitis.

artículo científico publicado en 2016

Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis

article

Quantification of low expressed SCD1 gene in colonic mucosa from patients with active ulcerative colitis

article

Reduced expression of mucin 9 (MUC9) in patients with ulcerative colitis

artículo científico publicado en 2011

Rheumatoid Arthritis Associated With Pemphigus Foliaceus in a Patient Not Taking Penicillamine

scientific article published on 01 September 2007

Role of the HLA-DQ locus in the development of chronic gastritis and gastric carcinoma in Mexican patients.

artículo científico publicado en 2006

Role of the interleukin 24 in patients with ulcerative colitis

artículo científico publicado en 2011

Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part).

artículo científico publicado en 2017

Synthesis of Interleukin-10 in Patients with Ulcerative Colitis and Helicobacter pylori Infection

artículo científico publicado en 2020

TLR9 mRNA expression is upregulated in patients with active ulcerative colitis

article

TRPV Subfamily (TRPV2, TRPV3, TRPV4, TRPV5, and TRPV6) Gene and Protein Expression in Patients with Ulcerative Colitis

artículo científico publicado en 2020

The Mexican consensus on probiotics in gastroenterology.

artículo científico publicado en 2017

The Mexican consensus on the diagnosis and treatment of ulcerative colitis

artículo científico publicado en 2018

The Transient Receptor Potential Vanilloid 1 Is Associated with Active Inflammation in Ulcerative Colitis

artículo científico publicado en 2018

Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.

artículo científico publicado en 2011

Tumor necrosis factor-α promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE)

article

Update on biosimilars in inflammatory bowel disease: Position and recommendations in Mexico.

artículo científico publicado en 2018

Lista de obras de Jesus Yamamoto-Furusho

Antinuclear antibodies: A marker associated with steroid dependence in patients with ulcerative colitis

Association of GIST and Somatostatinoma in a Patient With Type-1 Neurofibromatosis: Is There a Common Pathway?

Association of HLA-DR3 and HLA-DR4 with Sinonasal Polyposis in Mexican Mestizos

Association of HLA-DR4 (DRB1*0404) With Human Papillomavirus Infection in Patients With Focal Epithelial Hyperplasia

Association of HLA-DRB1*16 with chronic discoid lupus erythematosus in Mexican mestizo patients.

Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis

Association of the interleukin 15 (IL-15) gene polymorphisms with the risk of developing ulcerative colitis in Mexican individuals

Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease.

Centaurin beta1 down-regulates nucleotide-binding oligomerization domains 1- and 2-dependent NF-kappaB activation

Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis.

Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006).

Colonic epithelial upregulation of interleukin 22 (IL-22) in patients with ulcerative colitis

Complotype SC30 Is Associated With Susceptibility to Develop Ulcerative Colitis in Mexicans

Crohn's disease: innate immunodeficiency?

Cytomegalovirus Infection in Patients Who Required Colectomy for Toxic Megacolon or Severe Steroid-Refractory Ulcerative Colitis

Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.

Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis

Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.

Differential expression of occludin in patients with ulcerative colitis and healthy controls

Distinguishing Between Anti-Neutrophil Cytoplasmic Antibody Patterns in Inflammatory Bowel Disease: Is the “Atypical Pattern” Adding More Information?

Effect of Cis-palmitoleic acid supplementation on inflammation and expression of HNF4γ, HNF4α and IL6 in patients with ulcerative colitis.

Evaluation of a vaccination regimen and care in relation to follow-up and treatment of patients with inflammatory bowel disease

Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire

Expression of HNF4γ is downregulated in patients with active ulcerative colitis (UC) compared to UC patients in remission and healthy controls.

Expression of TOB/BTG Family members in Patients with Inflammatory Bowel Disease

Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study

Frequency, Clinical Features and Factors Associated with Pouchitis after Proctocolectomy with Ileo-Pouch-Anal Anastomosis in Patients with Ulcerative Colitis: A Latin-American Country Retrospective-Cohort Study

Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo

Gene Expression Profiling of Mediators Associated with the Inflammatory Pathways in the Intestinal Tissue from Patients with Ulcerative Colitis

Gene and protein expression of centaurin beta 1 (CENTB1) are up-regulated in patients with ulcerative colitis ⬇️

Gene expression of carnitine organic cation transporters 1 and 2 (OCTN) is downregulated in patients with ulcerative colitis.

Gene expression of solute carrier family 9 (sodium/hydrogen exchanger) 3, (SLC9A3) is downregulated in patients with ulcerative colitis.

Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.

Genetic factors associated with the development of inflammatory bowel disease.

Genetic polymorphisms of interleukin 20 (IL-20) in patients with ulcerative colitis.

Genetic polymorphisms of interleukin-22 in patients with ulcerative colitis.

HLA Study on Two Mexican Mestizo Families with Autoimmune Thyroid Disease

HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis.

HLA-DR6 (possibly DRB1*1301) is associated with susceptibility to Takayasu arteritis in Mexicans

HLA-DR7 in Association with Chlorpromazine-induced Lupus Anticoagulant (LA)

HLA-DRB1 alleles are associated with the clinical course of disease and steroid dependence in Mexican patients with ulcerative colitis.

HLA-DRB1*08 allele may help to distinguish between type 1 diabetes mellitus and type 2 diabetes mellitus in Mexican children.

HLA-DRB1∗04 is associated with the genetic susceptibility to develop vitiligo in Mexican patients with autoimmune thyroid disease

Haplotype Distribution of Class II MHC Genes in Mexican Patients with Systemic Lupus Erythematosus

High gene expression of CXCL8 is associated with the presence of extraintestinal manifestations and long-term disease in patients with ulcerative colitis.

High gene expression of MDR1 (ABCB1) is associated with medical treatment response and long-term remission in patients with ulcerative colitis.

Histopathologic Parameters at Diagnosis as Early Predictors of Histologic Remission along the Course of Ulcerative Colitis

IL-10-- and IL-20--expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis.

Immunologic, genetic and social human risk factors associated to histoplasmosis: studies in the State of Guerrero, Mexico ⬇️

Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.

Increased expression of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) and MMP10, MMP23 in inflammatory bowel disease: cross-sectional study

Increased expression of discs large homolog 5 gene (DLG5) in ulcerative colitis patients compared to healthy individuals.

Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study.

Infection frequency in patients with chronic idiopathic ulcerative colitis

Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.

Innate immunity in inflammatory bowel disease.

Innovative therapeutics for inflammatory bowel disease

Interleukin 1 β (IL-1B) and IL-1 Antagonist Receptor (IL-1RN) Gene Polymorphisms are Associated With the Genetic Susceptibility and Steroid Dependence in Patients With Ulcerative Colitis

Interleukin 17 gene and protein expression are increased in patients with ulcerative colitis

Interleukin 21 expression is increased in rectal biopsies from patients with ulcerative colitis.

Interleukin 27 is up-regulated in patients with active inflammatory bowel disease

Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease

Interleukin-18 upregulation is associated with the use of steroids in patients with ulcerative colitis

Intestinal protozoa infections among patients with ulcerative colitis: prevalence and impact on clinical disease course.

Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study

Leiden V Factor and Spastic Cerebral Palsy in Mexican Children

Marcadores serológicos en enfermedad inflamatoria intestinal: diferencias poblacionales y limitaciones de su aplicación

Mild clinical behaviour of Crohn disease in elderly patients in a Latin American country: A case-control study

Mortality and Hospitalizations in Mexican Patients with Inflammatory Bowel Disease: Results from a Nationwide Health Registry

Perinuclear anti-neutrophil cytoplasmic antibodies (p-anca) in chronic ulcerative colitis: experience in a Mexican institution.

Peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression is downregulated in patients with active ulcerative colitis.

Peroxisome proliferator-activated receptors family is involved in the response to treatment and mild clinical course in patients with ulcerative colitis

Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies

Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.

Protective role of Interleukin 27 (IL-27) gene polymorphisms in patients with ulcerative colitis.

Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis

Quantification of low expressed SCD1 gene in colonic mucosa from patients with active ulcerative colitis